Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Angiography | 20 | 2024 | 4576 | 2.730 |
Why?
|
Coronary Artery Disease | 26 | 2024 | 6485 | 2.510 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 8 | 2020 | 1184 | 2.500 |
Why?
|
Plaque, Atherosclerotic | 11 | 2024 | 1518 | 2.270 |
Why?
|
Coronary Vessels | 15 | 2024 | 3106 | 2.000 |
Why?
|
Fractional Flow Reserve, Myocardial | 3 | 2020 | 289 | 1.240 |
Why?
|
Heart Valve Prosthesis | 7 | 2021 | 1489 | 0.890 |
Why?
|
Chest Pain | 5 | 2022 | 1114 | 0.730 |
Why?
|
Models, Cardiovascular | 4 | 2020 | 996 | 0.710 |
Why?
|
Coronary Stenosis | 3 | 2020 | 833 | 0.680 |
Why?
|
Aortic Valve Stenosis | 5 | 2021 | 1955 | 0.620 |
Why?
|
Iopamidol | 2 | 2017 | 191 | 0.610 |
Why?
|
Troponin I | 1 | 2021 | 619 | 0.570 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 841 | 0.560 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2021 | 1537 | 0.540 |
Why?
|
Predictive Value of Tests | 14 | 2024 | 15067 | 0.540 |
Why?
|
Mitral Valve Stenosis | 1 | 2018 | 376 | 0.520 |
Why?
|
Mitral Valve | 3 | 2018 | 1491 | 0.440 |
Why?
|
Exercise Test | 1 | 2020 | 2074 | 0.440 |
Why?
|
Data Mining | 1 | 2017 | 537 | 0.430 |
Why?
|
Mitral Valve Insufficiency | 2 | 2018 | 1421 | 0.390 |
Why?
|
Acute Coronary Syndrome | 2 | 2021 | 2337 | 0.370 |
Why?
|
Heart Ventricles | 2 | 2020 | 3817 | 0.360 |
Why?
|
Thrombosis | 2 | 2020 | 2968 | 0.360 |
Why?
|
Adipose Tissue | 2 | 2023 | 3280 | 0.330 |
Why?
|
Calcinosis | 1 | 2018 | 1495 | 0.330 |
Why?
|
Decision Support Techniques | 2 | 2019 | 1956 | 0.320 |
Why?
|
Heart Transplantation | 2 | 2018 | 3113 | 0.320 |
Why?
|
Reproducibility of Results | 11 | 2021 | 19894 | 0.270 |
Why?
|
Middle Aged | 34 | 2024 | 213241 | 0.260 |
Why?
|
Observer Variation | 3 | 2020 | 2592 | 0.250 |
Why?
|
Aortic Valve | 5 | 2021 | 1920 | 0.250 |
Why?
|
Algorithms | 5 | 2018 | 13869 | 0.240 |
Why?
|
Cardiovascular Diseases | 4 | 2024 | 15142 | 0.240 |
Why?
|
Male | 38 | 2024 | 349776 | 0.230 |
Why?
|
Prognosis | 8 | 2024 | 29052 | 0.220 |
Why?
|
Risk Assessment | 5 | 2024 | 23327 | 0.190 |
Why?
|
Myocardial Bridging | 1 | 2020 | 11 | 0.190 |
Why?
|
Humans | 49 | 2024 | 743811 | 0.190 |
Why?
|
Atherosclerosis | 3 | 2023 | 3445 | 0.190 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2019 | 143 | 0.180 |
Why?
|
Markov Chains | 2 | 2020 | 968 | 0.180 |
Why?
|
Female | 33 | 2024 | 380020 | 0.180 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2016 | 531 | 0.180 |
Why?
|
Twins, Dizygotic | 2 | 2017 | 235 | 0.180 |
Why?
|
Prospective Studies | 10 | 2022 | 53250 | 0.170 |
Why?
|
Quinolines | 1 | 2024 | 732 | 0.170 |
Why?
|
Twins, Monozygotic | 2 | 2017 | 458 | 0.160 |
Why?
|
Aged | 19 | 2023 | 163178 | 0.160 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11708 | 0.160 |
Why?
|
Arterio-Arterial Fistula | 1 | 2018 | 19 | 0.160 |
Why?
|
Coronary Occlusion | 1 | 2020 | 304 | 0.150 |
Why?
|
Social Isolation | 1 | 2020 | 367 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
Genetic Determinism | 1 | 2016 | 10 | 0.150 |
Why?
|
Coronary Circulation | 2 | 2020 | 1572 | 0.140 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 709 | 0.140 |
Why?
|
Abdominal Fat | 1 | 2017 | 223 | 0.130 |
Why?
|
Prosthesis Failure | 2 | 2019 | 1203 | 0.130 |
Why?
|
Temperament | 1 | 2017 | 283 | 0.130 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2016 | 71 | 0.130 |
Why?
|
Erythrocyte Indices | 1 | 2016 | 146 | 0.130 |
Why?
|
Hemodynamics | 3 | 2020 | 4197 | 0.130 |
Why?
|
Injections, Intravenous | 1 | 2017 | 1422 | 0.120 |
Why?
|
Personality Inventory | 1 | 2017 | 1030 | 0.120 |
Why?
|
Hydrodynamics | 3 | 2020 | 158 | 0.120 |
Why?
|
Body Surface Potential Mapping | 1 | 2016 | 238 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2018 | 974 | 0.120 |
Why?
|
Coronary Thrombosis | 1 | 2017 | 495 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 21675 | 0.120 |
Why?
|
Retrospective Studies | 8 | 2021 | 77410 | 0.120 |
Why?
|
Adenosine | 1 | 2018 | 825 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2020 | 856 | 0.110 |
Why?
|
Echocardiography, Doppler | 1 | 2017 | 935 | 0.110 |
Why?
|
Single-Blind Method | 1 | 2017 | 1586 | 0.110 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2018 | 555 | 0.110 |
Why?
|
Complement System Proteins | 1 | 2016 | 796 | 0.110 |
Why?
|
Pericardium | 1 | 2017 | 667 | 0.110 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15526 | 0.110 |
Why?
|
Aorta | 2 | 2021 | 2062 | 0.110 |
Why?
|
HIV Infections | 3 | 2024 | 16715 | 0.110 |
Why?
|
Calcium | 2 | 2023 | 5755 | 0.110 |
Why?
|
Feasibility Studies | 2 | 2021 | 5078 | 0.110 |
Why?
|
Treatment Outcome | 7 | 2021 | 63042 | 0.110 |
Why?
|
Intra-Abdominal Fat | 1 | 2017 | 591 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 6 | 2021 | 20121 | 0.100 |
Why?
|
Radiation Dosage | 2 | 2017 | 1928 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2016 | 1572 | 0.100 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5388 | 0.090 |
Why?
|
Heart | 1 | 2024 | 4460 | 0.090 |
Why?
|
Adiposity | 1 | 2020 | 1806 | 0.090 |
Why?
|
Visual Perception | 1 | 2018 | 1414 | 0.090 |
Why?
|
Inflammation | 3 | 2024 | 10629 | 0.090 |
Why?
|
Heart Valve Diseases | 1 | 2017 | 1073 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3255 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3587 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14714 | 0.080 |
Why?
|
Health Policy | 1 | 2020 | 2662 | 0.080 |
Why?
|
Surgery, Computer-Assisted | 1 | 2016 | 1017 | 0.080 |
Why?
|
Clinical Competence | 2 | 2020 | 4687 | 0.080 |
Why?
|
Stents | 1 | 2019 | 3280 | 0.070 |
Why?
|
Contrast Media | 2 | 2017 | 5301 | 0.070 |
Why?
|
Peptide Fragments | 2 | 2016 | 5096 | 0.070 |
Why?
|
Risk Factors | 6 | 2023 | 72252 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2291 | 0.070 |
Why?
|
Health Care Costs | 1 | 2019 | 3207 | 0.070 |
Why?
|
Automation | 2 | 2018 | 584 | 0.070 |
Why?
|
Stress, Mechanical | 2 | 2020 | 1684 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10940 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8939 | 0.060 |
Why?
|
Software | 1 | 2017 | 4440 | 0.060 |
Why?
|
Prosthesis Design | 2 | 2020 | 2103 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 35409 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2016 | 2758 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3134 | 0.050 |
Why?
|
Heart Failure | 2 | 2016 | 10896 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Echocardiography | 3 | 2020 | 5096 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 642 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2017 | 4467 | 0.050 |
Why?
|
Hungary | 1 | 2020 | 84 | 0.050 |
Why?
|
Thorax | 1 | 2023 | 547 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7658 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39001 | 0.040 |
Why?
|
Shear Strength | 1 | 2020 | 165 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 3 | 2017 | 4033 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13112 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57744 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2023 | 21733 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 640 | 0.040 |
Why?
|
Elasticity | 1 | 2020 | 657 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 552 | 0.040 |
Why?
|
Lipoproteins | 1 | 2022 | 881 | 0.040 |
Why?
|
Adult | 6 | 2022 | 213889 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2016 | 5033 | 0.040 |
Why?
|
Learning Curve | 1 | 2018 | 208 | 0.040 |
Why?
|
Sinus of Valsalva | 1 | 2016 | 59 | 0.030 |
Why?
|
HIV | 1 | 2023 | 1604 | 0.030 |
Why?
|
Tomography, Spiral Computed | 1 | 2017 | 280 | 0.030 |
Why?
|
North America | 1 | 2019 | 1249 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15281 | 0.030 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2017 | 272 | 0.030 |
Why?
|
Heart Atria | 1 | 2021 | 1357 | 0.030 |
Why?
|
Certification | 1 | 2018 | 423 | 0.030 |
Why?
|
Models, Economic | 1 | 2019 | 712 | 0.030 |
Why?
|
Complement Activation | 1 | 2016 | 453 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 680 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 925 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 25032 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 1225 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1683 | 0.030 |
Why?
|
Prevalence | 2 | 2020 | 15211 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1486 | 0.030 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2017 | 591 | 0.030 |
Why?
|
Motion | 1 | 2016 | 798 | 0.030 |
Why?
|
Conscious Sedation | 1 | 2016 | 527 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8637 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3758 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12020 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
Reoperation | 1 | 2019 | 4200 | 0.020 |
Why?
|
Artifacts | 1 | 2017 | 1904 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3660 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2021 | 3965 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5002 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2020 | 2657 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8316 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3320 | 0.020 |
Why?
|
Image Enhancement | 1 | 2016 | 2915 | 0.020 |
Why?
|
Endovascular Procedures | 1 | 2017 | 1980 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16361 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10251 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12944 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40545 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 12788 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40038 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17439 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56392 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 85729 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168660 | 0.000 |
Why?
|